137 related articles for article (PubMed ID: 37160190)
1. Treatment of Cancer-Associated Retinopathy: A Systematic Literature Review.
Brossard-Barbosa N; Dezard V; Margolin E
Ophthalmol Retina; 2023 Sep; 7(9):819-828. PubMed ID: 37160190
[TBL] [Abstract][Full Text] [Related]
2. Cystoid macular edema from cancer-associated retinopathy.
Moyer K; DeWilde A; Law C
Optom Vis Sci; 2014 Apr; 91(4 Suppl 1):S66-70. PubMed ID: 24531653
[TBL] [Abstract][Full Text] [Related]
3. Treatment of cancer-associated retinopathy with rituximab.
Dy I; Chintapatla R; Preeshagul I; Becker D
J Natl Compr Canc Netw; 2013 Nov; 11(11):1320-4. PubMed ID: 24225966
[TBL] [Abstract][Full Text] [Related]
4. Unilateral cancer-associated retinopathy: diagnosis, serology and treatment.
Roels D; Ueno S; Talianu CD; Draganova D; Kondo M; Leroy BP
Doc Ophthalmol; 2017 Dec; 135(3):233-240. PubMed ID: 28815346
[TBL] [Abstract][Full Text] [Related]
5. Plasma exchange response in 34 patients with severe optic neuritis.
Deschamps R; Gueguen A; Parquet N; Saheb S; Driss F; Mesnil M; Vignal C; Aboab J; Depaz R; Gout O
J Neurol; 2016 May; 263(5):883-887. PubMed ID: 26964539
[TBL] [Abstract][Full Text] [Related]
6. TRIPLE THERAPY WITH RITUXIMAB, INTRAVENOUS IMMUNOGLOBULIN, AND INTRAVITREAL CORTICOSTEROIDS FOR MELANOMA-ASSOCIATED RETINOPATHY: TTRIIC DOES THE TRICK.
Hamdan SA; Breazzano MP; Daniels AB
Retin Cases Brief Rep; 2022 Nov; 16(6):775-778. PubMed ID: 33165302
[TBL] [Abstract][Full Text] [Related]
7. Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases.
Guy J; Aptsiauri N
Arch Ophthalmol; 1999 Apr; 117(4):471-7. PubMed ID: 10206574
[TBL] [Abstract][Full Text] [Related]
8. The potential role of plasma exchange as a treatment for bilateral diffuse uveal melanocytic proliferation: a report of two cases.
Jaben EA; Pulido JS; Pittock S; Markovic S; Winters JL
J Clin Apher; 2011 Dec; 26(6):356-61. PubMed ID: 21898575
[TBL] [Abstract][Full Text] [Related]
9. Non-paraneoplastic autoimmune retinopathy that developed in fellow eye 10 years after onset in first eye: a case report.
Miura G; Baba T; Iwase T; Ohde H; Kanda A; Saito W; Ishida S; Yamamoto S
BMC Ophthalmol; 2020 Apr; 20(1):132. PubMed ID: 32252709
[TBL] [Abstract][Full Text] [Related]
10. Treatment outcomes of first-ever episode of severe optic neuritis.
Galetta K; Ryan S; Manzano G; Chibnik LB; Balaban D; Prasad S; Chwalisz BK; Salazar-Camelo A; Conway S; Levy M; Matiello M
Mult Scler Relat Disord; 2022 Oct; 66():104020. PubMed ID: 35839615
[TBL] [Abstract][Full Text] [Related]
11. Cancer-associated retinopathy preceding the diagnosis of cancer.
Hoogewoud F; Butori P; Blanche P; Brézin AP
BMC Ophthalmol; 2018 Nov; 18(1):285. PubMed ID: 30390655
[TBL] [Abstract][Full Text] [Related]
12. Treatment of acute relapses in neuromyelitis optica: Steroids alone versus steroids plus plasma exchange.
Abboud H; Petrak A; Mealy M; Sasidharan S; Siddique L; Levy M
Mult Scler; 2016 Feb; 22(2):185-92. PubMed ID: 25921047
[TBL] [Abstract][Full Text] [Related]
13. Outcomes Associated With Sustained-Release Intraocular Fluocinolone Implants in a Case of Melanoma-Associated Retinopathy Treated Without Systemic Immunosuppression.
Karatsai E; Robson AG; Taylor SRJ
JAMA Ophthalmol; 2019 May; 137(5):564-567. PubMed ID: 30896772
[TBL] [Abstract][Full Text] [Related]
14. Efficacy and Safety of Plasma Exchange as an Adjunctive Therapy for Rapidly Progressive IgA Nephropathy and Henoch-Schönlein Purpura Nephritis: A Systematic Review.
Nguyen B; Acharya C; Tangpanithandee S; Miao J; Krisanapan P; Thongprayoon C; Amir O; Mao MA; Cheungpasitporn W; Acharya PC
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835388
[TBL] [Abstract][Full Text] [Related]
15. Unilateral cancer-associated retinopathy: a case report.
Javaid Z; Rehan SM; Al-Bermani A; Payne G
Scott Med J; 2016 Aug; 61(3):155-159. PubMed ID: 26246524
[TBL] [Abstract][Full Text] [Related]
16. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
17. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.
Solomon SD; Lindsley K; Vedula SS; Krzystolik MG; Hawkins BS
Cochrane Database Syst Rev; 2019 Mar; 3(3):CD005139. PubMed ID: 30834517
[TBL] [Abstract][Full Text] [Related]
18. Intravenous rituximab and oral cyclophosphamide for the treatment of cancer‑associated retinopathy in a patient with epithelial ovarian cancer: A case report.
Andrikopoulou A; Koutsoukos K; Chatziralli I; Theodossiadis P; Tsivgoulis G; Tzartos J; Anastasakis A; Zagouri F; Dimopoulos MA
Oncol Lett; 2023 Jul; 26(1):308. PubMed ID: 37332336
[TBL] [Abstract][Full Text] [Related]
19. Cancer-Associated Retinopathy and Treatment with Intravenous Immunoglobulin Therapy. A Seldom Used Approach?
Ramos-Ruperto L; Busca-Arenzana C; Boto-de Los Bueis A; Schlincker A; Arnalich-Fernández F; Robles-Marhuenda Á
Ocul Immunol Inflamm; 2021 Feb; 29(2):399-402. PubMed ID: 31710513
[No Abstract] [Full Text] [Related]
20. Cancer-associated retinopathy: update on pathogenesis and therapy.
Shildkrot Y; Sobrin L; Gragoudas ES
Semin Ophthalmol; 2011; 26(4-5):321-8. PubMed ID: 21958182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
